share_log

南京医药(600713.SH):发行可转债申请获得上交所受理

Nanjing Pharmaceutical (600713.SH): Application to issue convertible bonds accepted by the Shanghai Stock Exchange

Gelonghui Finance ·  Jan 18 02:44

Gelonghui, January 18, 丨 Nanjing Pharmaceutical (600713.SH) announced that on January 17, 2024, the company received the “Notice on Accepting the Application for Issuance of Securities by Nanjing Pharmaceutical Co., Ltd. Shanghai Main Board Listed Company” (Shanghai Stock Exchange) (Shanghai Stock Exchange) [2024] No. 20) issued by the Shanghai Stock Exchange (hereinafter referred to as the “Shanghai Stock Exchange”). The Shanghai Stock Exchange checked the prospectus and related application documents submitted by the company for the issuance of securities by a company listed on the Shanghai Main Board. It believed that the application documents were complete and complied with the legal form, and decided to accept them and review them in accordance with the law.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment